Literature DB >> 22192821

Inhibition of Rho kinases increases directional motility of microvascular endothelial cells.

Johannes Breyer1, Jana Samarin, Margot Rehm, Lena Lautscham, Ben Fabry, Margarete Goppelt-Struebe.   

Abstract

Rho kinases are major regulators of actin cytoskeletal organization and cell motility. Depending on the model system, inhibitors of Rho kinases (ROCK) have been reported to increase or decrease endothelial cell migration. In the present study we investigated the effect of Rho kinase inhibitors on microvascular endothelial cell migration with a special focus on the isoform ROCK2. Migration of microvascular endothelial cells was analyzed in a wound-healing, a spheroid-on-collagen migration assay and in cells embedded in collagen-1 gels. The non-selective Rho kinase inhibitor H1152 was compared to the selective ROCK2 inhibitor SLX2119 and to siRNA knock down. Non-selective inhibition of Rho kinases decreased cell-spanning F-actin fibers, loosened cell-cell contacts visualized by VE cadherin staining, and reduced cell-matrix interactions as shown by reduced Hic-5 expression in focal contacts. Rho kinase inhibitors facilitated directed migration of endothelial cells away from spheroids on fibronectin-coated plates and in collagen-1 gels. By contrast, migration of firmly attached endothelial cells, resembling intact vessels, was not promoted by Rho kinase inhibition. Selective inhibition of ROCK2 mimicked the cytoskeletal effects of H1152 and also increased cell motility, although to a lesser extent. In summary, Rho kinase inhibition enhanced the migration and cytoskeletal restructuring preferentially in freshly attached endothelial cells. ROCK2 may be a potential target to manipulate endothelial cell migration after vessel injury.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22192821     DOI: 10.1016/j.bcp.2011.12.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue.

Authors:  Zhenan Liu; Jie Wen; Xue Leng; Qian Zhou; Changkuo Zhou; Huaqiang Zhao; Xunwei Wu
Journal:  J Vis Exp       Date:  2018-08-25       Impact factor: 1.355

2.  ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension.

Authors:  Cora M L Beckers; Nebojsa Knezevic; Erik T Valent; Mohammad Tauseef; Ramaswamy Krishnan; Kavitha Rajendran; C Corey Hardin; Jurjan Aman; Jan van Bezu; Paul Sweetnam; Victor W M van Hinsbergh; Dolly Mehta; Geerten P van Nieuw Amerongen
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

3.  Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity.

Authors:  S Fernandes; S Salta; J Bravo; A P Silva; T Summavielle
Journal:  Mol Neurobiol       Date:  2014-12-03       Impact factor: 5.590

4.  Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells.

Authors:  Michael Hauke; Robert Eckenstaler; Anne Ripperger; Anna Ender; Heike Braun; Ralf A Benndorf
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

Review 5.  ROCKs as immunomodulators of stroke.

Authors:  Qing Mei Wang; James K Liao
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

6.  Embedded Spheroids as Models of the Cancer Microenvironment.

Authors:  Kristie M Tevis; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Biosyst       Date:  2017-08-18

7.  Branched actin networks push against each other at adherens junctions to maintain cell-cell adhesion.

Authors:  Nadia Efimova; Tatyana M Svitkina
Journal:  J Cell Biol       Date:  2018-03-05       Impact factor: 10.539

8.  Selective ROCK2 Inhibition In Focal Cerebral Ischemia.

Authors:  Jeong Hyun Lee; Yi Zheng; Daniel von Bornstadt; Ying Wei; Aygul Balcioglu; Ali Daneshmand; Nilufer Yalcin; Esther Yu; Fanny Herisson; Yahya B Atalay; Maya Hwewon Kim; Yong-Joo Ahn; Mustafa Balkaya; Paul Sweetnam; Olivier Schueller; Masha V Poyurovsky; Hyung-Hwan Kim; Eng H Lo; Karen L Furie; Cenk Ayata
Journal:  Ann Clin Transl Neurol       Date:  2014-01-01       Impact factor: 4.511

9.  HIF-1α activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cells.

Authors:  Alexander Weidemann; Johannes Breyer; Margot Rehm; Kai-Uwe Eckardt; Christoph Daniel; Iwona Cicha; Klaudia Giehl; Margarete Goppelt-Struebe
Journal:  Cell Commun Signal       Date:  2013-10-21       Impact factor: 5.712

Review 10.  Targeting Rho-GTPases in immune cell migration and inflammation.

Authors:  Maté Biro; Marcia A Munoz; Wolfgang Weninger
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.